124.25400 USD
1.274
1.04%
Last update May 30, 4:12 PM BST
Main market
Day range
123.019997
124.59000
Previous close
122.98000
Open
123.25
Access this stock data via API
Subscribe
Abbott Laboratories
124.25
1.27
1.04%

Financials

Income statement

Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 11.4B 11.1B 10.4B 11.0B
Cost of revenue 5.1B 4.9B 4.5B 4.9B
Gross profit 6.3B 6.3B 5.9B 6.0B
Operating expense
Research & development 766M 725M 716M 749M
Selling general and admin 3.1B 3.1B 3.1B 2.9B
Other operating expenses
Operating income 2.1B 2.1B 1.7B 1.9B
Non operating interest income
Income 77M 71M 82M 91M
Expense 121M 121M 131M 136M
Other income expense 167M 148M 134M 164M
Pretax income 2.2B 2.2B 1.8B 2.0B
Tax provision 536M 371M 453M -7.2B
Net income 1.6B 1.8B 1.3B 9.2B
Basic EPS 1.0 0.8 5.3
Diluted EPS 1.0 0.8 5.3
Basic average shares 1.7B 1.7B 1.7B
Diluted average shares 1.8B 1.7B 1.7B
EBITDA 3.1B 3.0B 2.7B 3.0B
Net income from continuing op. 1.6B 1.8B 1.3B 9.2B
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 7 hours 39 minutes

08:50
00:00
08:00
16:30
23:59

Trading Hours (Monday - Friday):

Pre-market
07:15 - 08:00
Main market
08:00 - 16:30
Post-market
16:30 - 17:15
All times are displayed in the Europe/London timezone (GMT, UTC+00:00).